CLINICAL_TRIALS
trial_result
· 2021-07-14
Clinical Trial Update: A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation [Phase 3]
Summary
Phase 3 open-label retreatment study assessing safety and effectiveness of PN40082 for lip augmentation has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prollenium Medical Technologies Inc. | Conditions: Lip Augmentation | Phase 3 | Status: COMPLETED | Results posted: 2021-07-14